Sunday - September 7, 2025
FDA Issues Warning Letter to Maple Organics
August 21, 2025
WASHINGTON, Aug. 21 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Everlaan Organics Inc. dba Maple Organics from Center for Drug Evaluation and Research:

* * *

Recipient: Ms. Rosy Atwal, Founder and CEO, Everlaan Organics, Inc. dba Maple Organics, 17220 Heather Dr, Unit 106, Surrey BC V3S 8G6, Canada

Issuing Office: Center for Drug Evaluation and Research (CDER), United States
< . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products